Novogen Limited Stock Australian S.E.
Equities
AU000000NRT0
Biotechnology & Medical Research
Sales 2022 | 10K 6.47K | Sales 2023 | 555 358.97 | Capitalization | 39.72M 25.69M |
---|---|---|---|---|---|
Net income 2022 | -24M -15.52M | Net income 2023 | -20M -12.94M | EV / Sales 2022 | 7,714 x |
Net cash position 2022 | 7.36M 4.76M | Net cash position 2023 | 3.44M 2.23M | EV / Sales 2023 | 65,355 x |
P/E ratio 2022 |
-3.27
x | P/E ratio 2023 |
-1.55
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 45.6% |
Latest transcript on Novogen Limited
1st Jan change | Capi. | |
---|---|---|
+0.17% | 42.86B | |
+10.92% | 42.74B | |
+44.30% | 41.36B | |
-6.20% | 27.68B | |
+5.23% | 25.15B | |
-24.79% | 18.63B | |
+26.69% | 12.37B | |
-3.13% | 11.92B | |
+6.57% | 11.21B |